Holen Sie sich die Stockscreener-App
718.67
0.31%
-2.22
Handel nachbörslich:
717.68
-0.99
-0.14%
Schlusskurs vom Vortag:
$720.89
Offen:
$726.505
24-Stunden-Volumen:
12.57M
Relative Volume:
0.76
Marktkapitalisierung:
$1.83T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
26.13
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-1.29%
1M Leistung:
+9.94%
6M Leistung:
+14.37%
1J Leistung:
-2.02%
1-Tages-Spanne:
$716.20
$728.07
1-Wochen-Bereich:
$711.68
$747.60
52-Wochen-Spanne:
$520.26
$779.82
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
718.67 | 1.83T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
351.66 | 4.30T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
347.86 | 4.25T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
529.14 | 108.78B | 20.32B | 3.16B | 3.82B | 12.55 |
RDDT
Reddit Inc
|
159.91 | 30.77B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-09-25 | Bestätigt | Canaccord Genuity | Buy |
| 2026-09-25 | Bestätigt | Deutsche Bank | Buy |
| 2026-09-25 | Bestätigt | Piper Sandler | Overweight |
| 2026-09-25 | Bestätigt | TD Cowen | Buy |
| 2026-09-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-09-21 | Bestätigt | Wells Fargo | Overweight |
| 2026-09-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2026-08-27 | Bestätigt | Rosenblatt | Buy |
| 2026-08-27 | Bestätigt | Truist | Buy |
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply LowerHBSS - GlobeNewswire Inc.
Fastly: Riding the Agentic AI Wave - Zacks Investment Research
Nvidia and AMD Lead the AI Market. 1 Chip Stock Has Far Greater Upside. - The Motley Fool
$5,000 Invested in Nvidia 5 Years Ago Would Be Worth $58,045 Today. Here’s How Much a $5,000 Investment Today Could Be Worth by 2031 - The Motley Fool
Navigating the AI Boom: Bubble is NOT a Four-Letter Word - Zacks Investment Research
Buy Cisco Systems as Leader of the AI Cloud Networking Space for 2027 - Zacks Investment Research
How to Play AI Theme With ETFs Amid Overvaluation Concerns? - Zacks Investment Research
Guide to Magnificent Seven ETF investing - Zacks Investment Research
Should You Forget Nvidia and Buy These 2 Artificial Intelligence (AI) Chip Stocks Instead? - The Motley Fool
Better Cloud AI Pick: CoreWeave or Nebius Group? - The Motley Fool
Meet the Super Semiconductor Stock Crushing Nvidia in 2026 - The Motley Fool
ETFs to Benefit as Nasdaq's Breakthrough Still Matters - Zacks Investment Research
Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal. - The Motley Fool
Meta (META) COO sells 1,575 shares at $728.08 each under a preset trading plan. - Stock Titan
Why Meta Platforms (META) Dipped More Than Broader Market Today - Zacks Investment Research
Is Google the Market's Biggest Artificial Intelligence (AI) Mistake? The Stock Is Priced Like a Loser. - The Motley Fool
SpaceX vs. Nvidia: Which Is the Better Trillion-Dollar Artificial Intelligence (AI) Stock for 2027? - The Motley Fool
Prediction: Custom Silicon Will Be the Next Boom Within the AI Supercycle. 1 Growth Stock to Own. - The Motley Fool
Advanced Micro Devices vs. Broadcom: Which Semiconductor Stock Is a Better Buy in 2026? - The Motley Fool
Meta's Muse Reached More Than Half of Customers Cequence Studied in Two Weeks Without Identifying Itself as an AI Agent - GlobeNewswire Inc.
Broadcom's AI Revenue Is Growing at 221%. Here's Why Custom Chips Could Be a Bigger Business Than GPUs. - The Motley Fool
Zacks Investment Ideas feature highlights: Advanced Micro, Tesla, Meta and SpaceX - Zacks Investment Research
Qualcomm's AI Infrastructure Pivot Is Underappreciated - The Motley Fool
Department of Energy Announces a New Multi-Billion-Dollar Nuclear Energy Deal - The Motley Fool
Form 4 Meta Platforms Inc For: 6 October By Investing.com - Investing.com Nigeria
Why I Don't Think Meta's AI Strategy Will Be Successful - The Motley Fool
Form 4 Meta Platforms Inc For: 6 October By Investing.com - Investing.com Canada
History Says Infrastructure Booms Create Winners and Losers. Here Are 3 AI Cloud Stocks to Watch. - The Motley Fool
Form 4 Meta Platforms Inc For: 6 October By Investing.com - Investing.com UK
Here's Why SpaceX's AI Infrastructure in Space "Moonshot" Won't Uproot Neocloud Companies - The Motley Fool
5 Key AI Investment News Items - Zacks Investment Research
Zacks Investment Ideas feature highlights: NVIDIA's, Alphabet's, Meta, Expedia, Apple and MongoDB - Zacks Investment Research
The 9 Best Stocks to Buy Right Now in October (2026) - The Motley Fool
Nebius Has Been One of 2026's Best-Performing AI Cloud Stocks. Here's What $1,000 Invested Could Be Worth by 2030. - The Motley Fool
Prediction: $5,000 Invested in Broadcom Could Be Worth This Much in 2028 - The Motley Fool
Meta Muse: Sparking the AI Revolution - Zacks Investment Research
Zacks Market Edge Highlights: Meta, NVIDIA and Microsoft - Zacks Investment Research
Prediction: Alphabet's Profit Growth Carries It to $5 Trillion Before 2028 - The Motley Fool
Nebius Has $40 Billion of Customer Commitments. Most of It Comes From 2 Customers. - The Motley Fool
Peter Thiel Was an Early Outside Investor in Facebook and Co-Founded Both PayPal and Palantir Before Building a Hedge Fund Now Concentrated in Power and Energy Stocks. Here's What That Track Record Says About Following His Contrarian Bets. - The Motley Fool
Meta's Muse AI: Good or Bad for E-Commerce? Shopify and Amazon Are Taking Opposite Approaches. - The Motley Fool
3 Trends That Will Push Copper Higher in 2028 - The Motley Fool
The S&P 500 Is Not Enough: My 3-Stock Starter Portfolio for New Investors - The Motley Fool
This Stock Posted the Best Performance in the “Magnificent Seven” in September. (Hint: It’s Not Nvidia.) - The Motley Fool
Breakfast News: The 20-Year Stock Challenge - The Motley Fool
Form 4 Alphabet Inc Class A For: 2 October By Investing.com - Investing.com South Africa
Meta Platforms Stock Rose 25% in September. Is It Still a Buy in October? - The Motley Fool
Form 4 Alphabet Inc Class A For: 2 October By Investing.com - Investing.com Nigeria
Why AMD Stock Jumped 30% in September - The Motley Fool
Our Favorite Mag 7 Stocks to Buy Right Now - Zacks Investment Research
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
| Olivan Javier | Officer |
Sep 28 '26 |
Proposed Sale |
749.82 |
1,575 |
1,180,966 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
750.42 |
946 |
709,902 |
8,824 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
748.91 |
629 |
471,064 |
1,118 |
| Zuckerberg Mark | COB and CEO |
Sep 24 '26 |
Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Zuckerberg Mark | Officer |
Sep 24 '26 |
Proposed Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Olivan Javier | Officer |
Sep 21 '26 |
Proposed Sale |
680.27 |
1,575 |
1,071,425 |
0 |
| Cox Christopher K | Officer |
Sep 21 '26 |
Proposed Sale |
712.76 |
40,000 |
28,510,259 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 21 '26 |
Sale |
680.27 |
629 |
427,890 |
1,175 |
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):